Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Viral Suppression With Lower AIDS-Defining and Non–AIDS-Defining Cancer Incidence in HIV-Infected Veterans
Lesley S. Park, Janet P. Tate, Keith Sigel, et al.
Annals of Internal Medicine (2018) Vol. 169, Iss. 2, pp. 87-87
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses
Patrick S. Sullivan, Anna Satcher Johnson, Elizabeth Pembleton, et al.
The Lancet (2021) Vol. 397, Iss. 10279, pp. 1095-1106
Closed Access | Times Cited: 258
Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals
Janet P. Tate, Jonathan A C Sterne, Amy C. Justice
AIDS (2019) Vol. 33, Iss. 5, pp. 903-912
Open Access | Times Cited: 78
The effect of non-AIDS-defining cancers on people living with HIV
Elizabeth Y. Chiao, Anna E. Coghill, Darya Kizub, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 6, pp. e240-e253
Open Access | Times Cited: 59
A Review of Chronic Comorbidities in Adults Living With HIV: State of the Science
Allison R. Webel, Julie Schexnayder, Patricia A. Cioe, et al.
Journal of the Association of Nurses in AIDS Care (2021) Vol. 32, Iss. 3, pp. 322-346
Open Access | Times Cited: 44
HIV viral transcription and immune perturbations in the CNS of people with HIV despite ART
Shelli Farhadian, Ofir Lindenbaum, Jun Zhao, et al.
JCI Insight (2022) Vol. 7, Iss. 13
Open Access | Times Cited: 30
Human Immunodeficiency Virus/AIDS in the Era of Coronavirus Disease 2019: A Juxtaposition of 2 Pandemics
Robert W. Eisinger, Andrea M. Lerner, Anthony S. Fauci
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 9, pp. 1455-1461
Open Access | Times Cited: 36
Epidemiology of Kaposi’s Sarcoma
Sophie Grabar, Dominique Costagliola
Cancers (2021) Vol. 13, Iss. 22, pp. 5692-5692
Open Access | Times Cited: 36
Engineered Nanomaterials as Potential Candidates for HIV Treatment: Between Opportunities and Challenges
M. Abd Elkodous, Gharieb S. El‐Sayyad, Hebatallah A. Nasser, et al.
Journal of Cluster Science (2019) Vol. 30, Iss. 3, pp. 531-540
Closed Access | Times Cited: 40
Sustained HIV viral suppression among men who have sex with men in the Miami-Dade County Ryan White Program: the effect of demographic, psychosocial, provider and neighborhood factors
Diana M. Sheehan, Rahel Dawit, Semiu O. Gbadamosi, et al.
BMC Public Health (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 36
The Trends and Risk Factors of AIDS-Defining Cancers and Non-AIDS-Defining Cancers in Adults Living with and without HIV: A Narrative Review
Anikie Mathoma, Benn Sartorius, Saajida Mahomed
Journal of Cancer Epidemiology (2024) Vol. 2024, pp. 1-16
Open Access | Times Cited: 4
Spectrum and Incidence Trends of AIDS- and Non–AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS Cohort
Isabelle Poizot‐Martin, C. Lions, Clotilde Allavena, et al.
Cancer Epidemiology Biomarkers & Prevention (2020) Vol. 30, Iss. 3, pp. 554-563
Open Access | Times Cited: 30
HIV treatment, antiretroviral adherence and AIDS mortality in people who inject drugs: a scoping review
Anneli Uusküla, Jonathan Feelemyer, Don C. Des Jarlais
European Journal of Public Health (2023) Vol. 33, Iss. 3, pp. 381-388
Open Access | Times Cited: 10
Validity of Diagnostic Codes and Laboratory Tests to Identify Cholangiocarcinoma and Its Subtypes
Nicole Ferrante, Rebecca A. Hubbard, Kelley Weinfurtner, et al.
Pharmacoepidemiology and Drug Safety (2025) Vol. 34, Iss. 5
Open Access
Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA)
Helen C. Stankiewicz Karita, Kirsten Hauge, Amalia Magaret, et al.
JAMA Network Open (2019) Vol. 2, Iss. 4, pp. e190819-e190819
Open Access | Times Cited: 26
Drug-drug interactions in hiv-infected patients receiving chemotherapy
Chrystalyn Branch, Jan Parson-Martinez, Theodore J. Cory
Expert Opinion on Drug Metabolism & Toxicology (2024), pp. 1-13
Closed Access | Times Cited: 3
HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status
Jessie Torgersen, Michael J. Kallan, Dena M. Carbonari, et al.
JNCI Journal of the National Cancer Institute (2019) Vol. 112, Iss. 7, pp. 747-755
Open Access | Times Cited: 25
Timing of Antiretroviral Therapy Initiation and Risk of Cancer Among Persons Living With Human Immunodeficiency Virus
Michael J. Silverberg, Wendy A. Leyden, Raúl Ulises Hernández‐Ramírez, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 11, pp. 1900-1909
Open Access | Times Cited: 22
Excess cancer prevalence in men with HIV: A nationwide analysis of Medicaid data
Siran M. Koroukian, Guangjin Zhou, Suparna Navale, et al.
Cancer (2022) Vol. 128, Iss. 10, pp. 1987-1995
Closed Access | Times Cited: 13
Undetectable = Untransmittable and Your Health: The Personal Benefits of Early and Continuous Therapy for HIV Infection
Mark J. Siedner, Virginia A. Triant
The Journal of Infectious Diseases (2018) Vol. 219, Iss. 2, pp. 173-176
Open Access | Times Cited: 23
Determinants of Liver Complications Among HIV/Hepatitis B Virus–Coinfected Patients
Vincent Lo Re, Craig Newcomb, Dena M. Carbonari, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2019) Vol. 82, Iss. 1, pp. 71-80
Open Access | Times Cited: 20
Trajectories of Self-Reported Opioid Use Among Patients With HIV Engaged in Care: Results From a National Cohort Study
E. Jennifer Edelman, Yu Li, Declan T. Barry, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2020) Vol. 84, Iss. 1, pp. 26-36
Open Access | Times Cited: 20
Discrimination and Calibration of the Veterans Aging Cohort Study Index 2.0 for Predicting Mortality Among People With Human Immunodeficiency Virus in North America
Kathleen A. McGinnis, Amy C. Justice, Richard D. Moore, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 2, pp. 297-304
Open Access | Times Cited: 18
Changing Prevalence of AIDS and Non-AIDS-Defining Cancers in an Incident Cohort of People Living with HIV over 28 Years
Anna Maria Cattelan, Maria Mazzitelli, Nicolò Presa, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 70-70
Open Access | Times Cited: 7
Combining Charlson comorbidity and VACS indices improves prognostic accuracy for all-cause mortality for patients with and without HIV in the Veterans Health Administration
Kathleen A. McGinnis, Amy C. Justice, Vincent C. Marconi, et al.
Frontiers in Medicine (2024) Vol. 10
Open Access | Times Cited: 2
Computationally inferred cell-type specific epigenome-wide DNA methylation analysis unveils distinct methylation patterns among immune cells for HIV infection in three cohorts
Xinyu Zhang, Ying Hu, Ral E. Vandenhoudt, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 3, pp. e1012063-e1012063
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top